241 related articles for article (PubMed ID: 25505887)
1. Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe.
Patiño-Rodríguez O; Torres-Roque I; Martínez-Delgado M; Escobedo-Moratilla A; Pérez-Urizar J
Front Pharmacol; 2014; 5():261. PubMed ID: 25505887
[TBL] [Abstract][Full Text] [Related]
2. Absence of a significant pharmacokinetic interaction between atorvastatin and fenofibrate: a randomized, crossover, study of a fixed-dose formulation in healthy Mexican subjects.
Patiño-Rodríguez O; Martínez-Medina RM; Torres-Roque I; Martínez-Delgado M; Mares-García AS; Escobedo-Moratilla A; Covarrubias-Pinedo A; Arzola-Paniagua A; Herrera-Torres JL; Pérez-Urizar J
Front Pharmacol; 2015; 6():4. PubMed ID: 25688207
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers.
Park J; Kim CO; Jin BH; Yang S; Park MS; Hong T
Transl Clin Pharmacol; 2017 Dec; 25(4):202-208. PubMed ID: 32095476
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence of an ezetimibe/simvastatin combination tablet and coadministration of ezetimibe and simvastatin as separate tablets in healthy subjects.
Migoya EM; Bergman A; Hreniuk D; Matthews N; Yi B; Roadcap B; Valesky R; Liu L; Riffel K; Groff M; Zhao JJ; Musson DG; Gambale J; Kosoglou T; Statkevich P; Lasseter KC; Laurent A; Johnson-Levonas AO; Murphy G; Gottesdiener K; Paolini JF
Int J Clin Pharmacol Ther; 2006 Feb; 44(2):83-92. PubMed ID: 16502768
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of ezetimibe co-administered with atorvastatin in untreated patients with primary hypercholesterolaemia and coronary heart disease.
Blagden MD; Chipperfield R
Curr Med Res Opin; 2007 Apr; 23(4):767-75. PubMed ID: 17407633
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
Masana L; Mata P; Gagné C; Sirah W; Cho M; Johnson-Levonas AO; Meehan A; Troxell JK; Gumbiner B;
Clin Ther; 2005 Feb; 27(2):174-84. PubMed ID: 15811480
[TBL] [Abstract][Full Text] [Related]
7. Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance.
Thompson PD; MacDougall DE; Newton RS; Margulies JR; Hanselman JC; Orloff DG; McKenney JM; Ballantyne CM
J Clin Lipidol; 2016; 10(3):556-67. PubMed ID: 27206943
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
[TBL] [Abstract][Full Text] [Related]
9. Statin plus ezetimibe treatment in clinical practice: the SI-SPECT (Slovenia (SI) Statin Plus Ezetimibe in Cholesterol Treatment) monitoring of clinical practice study.
Fras Z; Mikhailidis DP
Curr Med Res Opin; 2008 Sep; 24(9):2467-76. PubMed ID: 18655751
[TBL] [Abstract][Full Text] [Related]
10. The short-term effect of atorvastatin plus ezetimibe therapy versus atorvastatin monotherapy on clinical outcome in acute coronary syndrome patients by gender.
Japaridze L; Sadunishvili M
Kardiol Pol; 2017; 75(8):770-778. PubMed ID: 28553847
[TBL] [Abstract][Full Text] [Related]
11. The Bioequivalence and Effect of Food on the Pharmacokinetics of a Fixed-Dose Combination Tablet Containing Rosuvastatin and Ezetimibe in Healthy Japanese Subjects.
Nishida C; Matsumoto Y; Fujimoto K; Shirakawa M; Wrishko RE; Behm MO; Furihata K
Clin Transl Sci; 2019 Nov; 12(6):704-712. PubMed ID: 31365188
[TBL] [Abstract][Full Text] [Related]
12. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
[TBL] [Abstract][Full Text] [Related]
14. Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia.
Ballantyne CM; Lipka LJ; Sager PT; Strony J; Alizadeh J; Suresh R; Veltri EP
Int J Clin Pract; 2004 Jul; 58(7):653-8. PubMed ID: 15311720
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
16. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
[TBL] [Abstract][Full Text] [Related]
17. Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease.
Barrios V; Amabile N; Paganelli F; Chen JW; Allen C; Johnson-Levonas AO; Massaad R; Vandormael K
Int J Clin Pract; 2005 Dec; 59(12):1377-86. PubMed ID: 16351668
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia.
Tuteja S; Duffy D; Dunbar RL; Movva R; Gadi R; Bloedon LT; Cuchel M
Pharmacotherapy; 2014 Mar; 34(3):227-39. PubMed ID: 24734312
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
[TBL] [Abstract][Full Text] [Related]
20. COMBINATION THERAPY EFFECTIVENESS OF EZETIMIBE AND ATORVASTATIN IN PATIENTS WITH ACUTE CORONARY SYNDROME.
Japaridze L; Sadunishvili M; Megreladze I
Georgian Med News; 2016 Mar; (252):15-22. PubMed ID: 27119829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
